Growth inhibition of malignant glioblastoma by DING protein

Journal of Neuro-Oncology

Volumn 107, Issue 2, 2012, Pages 247-256

  Bookland, Markus J ^a   Darbinian, Nune ^a   Weaver, Michael ^a   Amini, Shohreh ^a,b   Khalili, Kamel ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Temple University   (United States)

Author keywords

Cell cycle; DING; Glioma; P38SJ; Phosphatase

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE 1; CYCLIN E; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE; PROTEIN P38SJ; RADIOSENSITIZING AGENT; REGULATOR PROTEIN; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; CDC2 PROTEIN, HUMAN; CYCLIN B; DIAGNOSTIC AGENT; DNA BINDING PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; PLANT MEDICINAL PRODUCT; PROTEINASE K; RNF2 PROTEIN, HUMAN; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TRANSCRIPTION FACTOR E2F; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CALLUS (PLANT); CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN T98G; CELL STRAIN U 87MG; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTING; G1 PHASE CELL CYCLE CHECKPOINT; GENETIC TRANSFECTION; GLIOBLASTOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYPERICUM PERFORATUM; MOUSE; NONHUMAN; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; CELL CYCLE CHECKPOINT; CELL LINE; CHEMISTRY; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; HYPERICUM; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TIME; TUMOR CELL LINE;

ANIMALS; CELL CYCLE CHECKPOINTS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN B; CYCLIN E; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; ENDOPEPTIDASE K; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; GREEN FLUORESCENT PROTEINS; HUMANS; HYPERICUM; MICE; PLANT PREPARATIONS; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TRANSFECTION; UBIQUITIN-PROTEIN LIGASES;

EID: 84863575585     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-011-0743-x     Document Type: Article

References (47)

1. Karioti A, Bilia AR (2010) Hypericins as potential leads for new therapeutics. Int J Mol Sci 11:562-594
2. Suzuki O, Katsumata Y, Oya M et al (1984) Inhibition of monoamine oxidase by hypericin. Planta Med 50:272-274
3. Lavie G, Mandel M, Hazan S et al (2005) Anti-angiogenic activities of hypericin in vivo: potential for ophthalmologic applications. Angiogenesis 8:35-42
4. Davids LM, Kleemann B, Kacerovskà D et al (2008) Hypericin phototoxicity induces different modes of cell death in melanoma and human skin cells. J Photochem Photobiol B 91:67-76
5. Thomas C, Pardini RS (1992) Oxygen dependence of hypericininduced phototoxicity to EMT6 mouse mammary carcinoma cells. Photochem Photobiol 55:831-837
6. Agostinis P, Vantieghem A, Merlevede W et al (2002) Hypericin in cancer treatment: more light on the way. Int J Biochem Cell Biol 34:221-241
7. Ritz R, Wein HT, Dietz K, Schenk M, Roser F, Tatagiba M, Strauss WS (2007) Photodynamic therapy of malignant glioma with hypericin: comprehensive in vitro study in human glioblastoma cell lines. Int J Oncol 30(3):659-667
8. Schneider-Yin X, Kurmanaviciene A, Roth M et al (2009) Hypericin and 5-aminolevulinic acid-induced protoporphyrin IX induce enhanced phototoxicity in human endometrial cancer cells with non-coherent white light. Photodiagnosis Photodyn Ther 6:12-18
9. Kleban J, Szilardiova B, Mikes J et al (2006) Pre-treatment of HT-29 cells with 5-LOX inhibitor (MK-886) induces changes in cell cycle and increases apoptosis after photodynamic therapy with hypericin. J Photochem Photobiol B 84:79-88
10. Duo H, Olivo M, Mahendran R et al (2004) Modulation of matrix metalloproteinase-1 in nasopharyngeal cancer cells by photoactivation of hypericin. Int J Oncol 24:657-662
11. Miccoli L, Beurdeley-Thomas A, De PG et al (1998) Lightinduced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria. Cancer Res 58:5777-5786
12. Berlanda J, Kiesslich T, Oberdanner CB et al (2006) Characterization of apoptosis induced by photodynamic treatment with hypericin in A431 human epidermoid carcinoma cells. J Environ Pathol Toxicol Oncol 25:173-188
13. Assefa Z, Vantieghem A, Declercq W et al (1999) The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin. J Biol Chem 274:8788-8796
14. Buytaert E, Matroule JY, Durinck S et al (2008) Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells. Oncogene 27:1916-1929
15. Darbinian N, Czernik M, Darbinyan A, Elias M, Chabriere E, Bonasu S, Khalili K, Amini S (2009) Evidence for phosphatase activity of p27SJ and its impact on the cell cycle. J Cell Biochem 107(3):400-407
16. Darbinian-Sarkissian N, Darbinyan A, Otte J et al (2006) p27(SJ), a novel protein in St John's Wort, that suppresses expression of HIV-1 genome. Gene Ther 13:288-295
17. Darbinian N, Gomberg R, Mullen L et al (2011) Suppression of HIV-1 transcriptional elongation by a DING phophatase. J Cell Biochem 112:225-232
18. Diemer H, Elias M, Renault F et al (2008) Tandem use of X-ray crystallography and mass spectrometry to obtain ab initio the complete and exact amino acids sequence of HPBP, a human 38-kDa apolipoprotein. Proteins 71:1708-1720
19. Riah O, Dousset JC, Bofill-Cardona E et al (2000) Isolation and microsequencing of a novel cotinine receptor. Cell Mol Neurobiol 20:653-664
20. Berna A, Bernier F, Scott K et al (2002) Ring up the curtain on DING proteins. FEBS Lett 524:6-10
21. Berna A, Bernier F, Chabriere E et al (2008) DING proteins; novel members of a prokaryotic phosphate-binding protein superfamily which extends into the eukaryotic kingdom. Int J Biochem Cell Biol 40:170-175
22. Belenky M, Prasain J, Kim H, Barnes S (2003) DING, a genistein target in human breast cancer: a protein without a gene. J Nutr 133(Suppl 7):2497S-2501S
23. Scott K, Wu L (2005) Functional properties of a recombinant bacterial DING protein: comparison with a homologous human protein. Biochim Biophys Acta 1744:234-244
24. Ahn S, Moniot S, Elias M et al (2007) Structure-function relationships in a bacterial DING protein. FEBS Lett 581:3455-3460
25. Moniot S, Elias M, Kim D et al (2007) Crystallization, diffraction data collection and preliminary crystallographic analysis of DING protein from Pseudomonas fluorescens. Acta Crystallograph Sect F 63(Pt 7):590-592
26. Chen Z, Franco CF, Baptista RP et al (2007) Purification and identification of cutinases from Colletotrichum kahawae and Colletotrichum gloeosporioides. Appl Microbiol Biotechnol 73:1306-1313
27. Pantazaki AA, Tsolkas GP, Kyriakidis DA (2007) A DING phosphatase in Thermus thermophilus. Amino Acids 34:437-448
28. Perera T, Berna A, Scott K, Lemaitre-Guillier C et al (2008) Proteins related to St. John's Wort p27SJ, a suppressor of HIV-1 expression, are ubiquitous in plants. Phytochemistry 69:865-872
29. Lesner A, Li Y, Nitkiewicz J, Li G, Kartvelishvili A, Kartvelishvili M, Simm M (2005) A soluble factor secreted by an HIV-1 resistant cell line blocks transcription through inactivating the DNA-binding capacity of the NF-κB p65/p50 dimer. J Immunol 175:2548-2554
30. Amini S, Merabova N, Khalili K, Darbinian N (2009) p38SJ, a novel DINGG protein protects neuronal cells from alcohol induced injury and death. J Cell Physiol 221(3):499-504
31. Tsai LH, Harlow E, Meyerson M (1991) Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase. Nature 353:174-177
32. Meyerson M, Enders GH, Wu CL et al (1992) A family of human cdc2-related protein kinases. EMBO J 11:2909-2917
33. Neuman E, Sellers WR, McNeil JA et al (1996) Structure and partial genomic sequence of the human E2F1 gene. Gene 173:163-169
34. Morgan, David L (2007) The cell cycle: principles of control. New Science Press, London, pp 30-31
35. Amini S, Clavo A, Nadraga Y et al (2002) Interplay between cdk9 and NF-kappaB factors determines the level of HIV-1 gene transcription in astrocytic cells. Oncogene 21:5797-5803
36. Romano G, Giordano A (2008) Role of the cylcin-dependent kinase 9-related pathway in mammalian gene expression and human disease. Cell Cycle 7:3664-3668
37. Pirngruber J, Johnsen SA (2010) Induced G1 cell-cycle arrest controls replication-dependent histone mRNA 3' end processing through p21, NPAT and CDK9. Oncogene 29:2853-2963
38. Wang W, Heideman L, Chung CS, Pelling JC, Koehler KJ, Birt DF (2000) Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol Carcinog 28:102-110
39. Yoshida J, Ishibashi T, Nishio M (2007) G1 cell cycle arrest by amlodipine, a dihydropyridine Ca2+ channel blocker, in human epidermoid carcinoma A431 cells. Biochem Pharmacol 73(7):943-953
40. Brady G, Boggan L, Bowie A, O'Neill LA (2005) Schlafen-1 causes a cell cycle arrest by inhibiting induction of cyclin D1. J Biol Chem 280(35):30723-30734
41. Sonoda Y, Ozawa T, Aldape KD et al (2001) Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyt model of glioma. Cancer Res 61:6674-6678
42. Mure H, Matsuzaki K, Kitazato KT et al (2010) Akt2 and Akt3 play a pivotal role in malignant gliomas. Neuro Onc 12:221-232
43. Huang L, Li B, Li W et al (2009) ATP-sensitive potassium channels control glioma cells proliferation by regulating ERK activity. Carcinogenesis 30:737-744
44. Zhang L, Ma Y, Zhang J, Cheng J, Du J (2005) A new cellular signaling mechanism for angiotensin II activation of NF-kappaB: an IkappaB-independent, RSK-mediated phosphorylation of p65. Arterioscler Thromb Vasc Biol 25(6):1148-1153 Epub 2005 Mar 31
45. Santi SA, Lee H (2011) Ablation of Akt2 induces autophagy through cell cycle arrest, the downregulation of p70S6K, and the deregulation of mitochondria in MDA-MB231 cells. PLoS One 6(1):e14614
46. Wang M, Atayar C, Rosati S, Bosga-Bouwer A, Kluin P, Visser L (2009) JNK is constitutively active in mantle cell lymphoma: cell cycle deregulation and polyploidy by JNK inhibitor SP600125. J Pathol 218(1):95-103
47. Gangadhar NM, Firestein SJ, Stockwell BR (2008) A novel role for jun N-terminal kinase signaling in olfactory sensory neuronal death. Mol Cell Neurosci 38(4):518-525